Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Diltiazem (Cardizem) IV Bolus, Infusion Rate & Oral Transition Calculator frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Diltiazem (Cardizem) IV Bolus, Infusion Rate & Oral Transition Calculator?
The Diltiazem (Cardizem) IV Bolus, Infusion Rate & Oral Transition Calculator is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in cardiology practice. Calculates weight-based emergency IV boluses (0.25 mg/kg & 0.35 mg/kg), continuous IV pump infusion rates (5–15 mg/hr in mL/hr), and oral maintenance conversion dosing for acute rate control in atrial fibrillation and atrial flutter with RVR. Clinical scoring tools like Diltiazem (Cardizem) IV Bolus, Infusion Rate & Oral Transition Calculator are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
The premier bedside acute rate control protocol for emergency departments and cardiac stepdown units.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Diltiazem (Cardizem) IV Bolus, Infusion Rate & Oral Transition Calculator:
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 7.5 | Low Maintenance Infusion (5–7.5 mg/hr) | blue |
| 7.6 – 12.5 | Standard Titration Infusion (8–12.5 mg/hr) | green |
| ≥ 12.6 | High-Dose Maintenance Infusion (13–15+ mg/hr / Monitor BP) | yellow |
When to Exercise Caution
Contraindicated in Wolff-Parkinson-White syndrome with pre-excited AFib and severe systolic heart failure (LVEF < 40%).
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •January CT, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019;140(2):e125-e151.
- •Ellenbroek M, et al. Rate control in atrial fibrillation: comparison of intravenous diltiazem and metoprolol. Am J Cardiol. 2017;120(1):78-83.
- •Van Gelder IC, et al. Lenient versus strict rate control in patients with atrial fibrillation (RACE II trial). N Engl J Med. 2010;362(15):1363-1373.
Related Cardiology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Cardiology:
Body Surface Area (BSA)
Calculate BSA using the Mosteller formula.
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
Ideal Body Weight (IBW)
Calculate ideal body weight using the Devine formula.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
HEART Score for Major Cardiac Events
Predicts 6-week risk of major adverse cardiac events (MACE).